Kohima, August 20: The Nagaland Health Department has advised healthcare workers to exercise caution while prescribing or administering Tranexamic Acid, Ibuprofen and Aceclofenac following reports of adverse drug reactions associated with the medicines.
The advisory was issued by the Drugs Control Administration under the Department of Health & Family Welfare following a communication from the Drugs Controller General of India (DCGI), CDSCO, Ministry of Health & Family Welfare.
Based on recommendations of a subject expert committee reviewing adverse drug reactions reported under the Pharmacovigilance Programme of India, the advisory said Tranexamic Acid had been associated with back pain, while Ibuprofen and Aceclofenac had been linked to Fixed Drug Eruption (FDE), a skin reaction that can recur at the same site after exposure to a particular medicine.
Healthcare workers have been directed to remain vigilant and ensure proper follow-up of patients to identify and report suspected adverse reactions.
The circular, signed by L. Martemjen Longkumer, Controlling and Licensing Authority, Drugs Control Administration, Nagaland, was circulated to senior health officials, chief medical officers, medical superintendents of district and private hospitals and Drugs Control Officers for necessary surveillance and action.
The department said the advisory was issued in the interest of public health and patient safety. It also advised patients not to stop or change prescribed medication on their own, but to consult healthcare providers and report any suspected adverse reaction.
